These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 35140114)

  • 1. Advances in the management of cardioembolic stroke associated with patent foramen ovale.
    Mac Grory B; Ohman EM; Feng W; Xian Y; Yaghi S; Kamel H; Reznik ME
    BMJ; 2022 Feb; 376():e063161. PubMed ID: 35140114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcatheter closure of patent foramen ovale: Current evidence and future perspectives.
    Akagi T
    J Cardiol; 2021 Jan; 77(1):3-9. PubMed ID: 33144025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patent foramen ovale closure in the management of cryptogenic stroke: a review of current literature and guideline statements.
    Elzanaty AM; Patel N; Sabbagh E; Eltahawy EA
    Curr Med Res Opin; 2021 Mar; 37(3):377-384. PubMed ID: 33460329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke.
    Mas JL; Derumeaux G; Guillon B; Massardier E; Hosseini H; Mechtouff L; Arquizan C; Béjot Y; Vuillier F; Detante O; Guidoux C; Canaple S; Vaduva C; Dequatre-Ponchelle N; Sibon I; Garnier P; Ferrier A; Timsit S; Robinet-Borgomano E; Sablot D; Lacour JC; Zuber M; Favrole P; Pinel JF; Apoil M; Reiner P; Lefebvre C; Guérin P; Piot C; Rossi R; Dubois-Randé JL; Eicher JC; Meneveau N; Lusson JR; Bertrand B; Schleich JM; Godart F; Thambo JB; Leborgne L; Michel P; Pierard L; Turc G; Barthelet M; Charles-Nelson A; Weimar C; Moulin T; Juliard JM; Chatellier G;
    N Engl J Med; 2017 Sep; 377(11):1011-1021. PubMed ID: 28902593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk and fate of residual interatrial shunting after transcatheter closure of patent foramen ovale: a long term follow up study.
    Hammerstingl C; Bauriedel B; Stüsser C; Momcilovic D; Tuleta I; Nickenig G; Skowasch D
    Eur J Med Res; 2011 Jan; 16(1):13-9. PubMed ID: 21345765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patent foramen ovale and cryptogenic stroke: a matter of age?
    Handke M; Harloff A; Bode C; Geibel A
    Semin Thromb Hemost; 2009 Jul; 35(5):505-14. PubMed ID: 19739041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of detection of foramen ovale patent after cryptogenic ischemic stroke.
    Marinheiro R; Parreira L; Amador P; Silvestre I; Antunes C; Caria R
    J Echocardiogr; 2019 Mar; 17(1):44-51. PubMed ID: 30008156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants and clinical significance of persistent residual shunting in patients with percutaneous patent foramen ovale closure devices.
    Shafi NA; McKay RG; Kiernan FJ; Silverman IE; Ahlquist M; Silverman DI
    Int J Cardiol; 2009 Nov; 137(3):314-6. PubMed ID: 19616327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is Patent Foramen Ovale Closure More Effective Than Medical Therapy in Preventing Stroke Recurrence in Patients With Cryptogenic Stroke?: A Critically Appraised Topic.
    Valencia-Sanchez C; Fortuin FD; Sweeney JP; Ingall TJ; Marks LA; Wingerchuk DM; O'Carroll CB
    Neurologist; 2018 Sep; 23(5):175-180. PubMed ID: 30169372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patent foramen ovale closure by using transesophageal echocardiography for cryptogenic stroke: single center experience in 132 consecutive patients.
    Han Y; Zhang X; Zhang F
    J Cardiothorac Surg; 2020 Jan; 15(1):11. PubMed ID: 31918738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pearls and Pitfalls in the Transesophageal Echocardiographic Diagnosis of Patent Foramen Ovale.
    Song JK
    J Am Soc Echocardiogr; 2023 Sep; 36(9):895-905.e3. PubMed ID: 37196905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of echocardiographic and clinical characteristics in embolic stroke and migraine patients with patent foramen ovale.
    Polat F; Kaya Z; Yaylak B; Onuk T
    Echocardiography; 2024 Feb; 41(2):e15770. PubMed ID: 38379240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial Septal Aneurysm, Shunt Size, and Recurrent Stroke Risk in Patients With Patent Foramen Ovale.
    Turc G; Lee JY; Brochet E; Kim JS; Song JK; Mas JL;
    J Am Coll Cardiol; 2020 May; 75(18):2312-2320. PubMed ID: 32381162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patent foramen ovale closure with the SeptRx device initial experience with the first "In-Tunnel" device.
    Zimmermann WJ; Heinisch C; Majunke N; Staubach S; Russell S; Wunderlich N; Sievert H
    JACC Cardiovasc Interv; 2010 Sep; 3(9):963-7. PubMed ID: 20850097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Case for Selective Patent Foramen Ovale Closure After Cryptogenic Stroke.
    Wiktor DM; Carroll JD
    Circ Cardiovasc Interv; 2018 Mar; 11(3):e004152. PubMed ID: 29870380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transoesophageal echocardiography can help distinguish between patients with "symptomatic" and "asymptomatic" patent foramen ovale.
    Komar M; Podolec P; Przewłocki T; Wilkołek P; Tomkiewicz-Pająk L; Motyl R
    Kardiol Pol; 2012; 70(12):1258-63. PubMed ID: 23264244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dabigatran or Aspirin After Embolic Stroke of Undetermined Source in Patients With Patent Foramen Ovale: Results From RE-SPECT ESUS.
    Diener HC; Chutinet A; Easton JD; Granger CB; Kleine E; Marquardt L; Meyerhoff J; Zini A; Sacco RL
    Stroke; 2021 Mar; 52(3):1065-1068. PubMed ID: 33504190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryptogenic Stroke and High-Risk Patent Foramen Ovale: The DEFENSE-PFO Trial.
    Lee PH; Song JK; Kim JS; Heo R; Lee S; Kim DH; Song JM; Kang DH; Kwon SU; Kang DW; Lee D; Kwon HS; Yun SC; Sun BJ; Park JH; Lee JH; Jeong HS; Song HJ; Kim J; Park SJ
    J Am Coll Cardiol; 2018 May; 71(20):2335-2342. PubMed ID: 29544871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residual Shunt after Patent Foramen Ovale Device Closure in Patients With Cryptogenic Stroke: Serial Bubble Contrast Transesophageal Echocardiography Data.
    Moon J; Kim M; Oh PC; Shin DH; Park HM; Jo YY; Lee JS; Kang WC
    J Stroke Cerebrovasc Dis; 2019 Feb; 28(2):347-353. PubMed ID: 30396838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Embolic implications of combined risk factors in patients with patent foramen ovale (the CARPE criteria): consideration for primary prevention closure?
    Rigatelli G; Dell'Avvocata F; Giordan M; Braggion G; Aggio S; Chinaglia M; Roncon L; Cardaioli P; Chen JP
    J Interv Cardiol; 2009 Aug; 22(4):398-403. PubMed ID: 19515082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.